Living Well welcomes 5000th visitor and Klout goes beyond 50!

Living Well With Epilepsy welcomes the site’s 5000th unique visitor. That’s upwards of 13,500 pageviews. It was only a few months ago that we welcomed our 1000th visitor.

I hope you are enjoying the site and come back on a regular basis to participate in the conversation. As many of you who have heard from me directly know, feedback is welcome and encouraged. So, feel free to comment below and leave messages via twitter, facebook and linkedin.

Klout sails past 50
According to Klout.com, people really want to talk about epilepsy. The Klout Score is a measurement of overall online influence. The scores range from 1-100 with higher scores representing a wider and stronger sphere of influence. My score has been hovering in the high 40’s for a while now. But today I realized that it skipped 50 altogether and landed at 52. This is exciting because it means more people are likely to notice me stomping around writing about epilepsy. Maybe eventually my noise will eventually turn into real research dollars.

For now if you haven’t filled out the survey then please do. I’m gearing up for another review of your feedback.

Thanks for your visit and don’t forget, epilepsy is as common and as deadly as breast cancer.

Jessica K. Smith Founder and CEO; Executive Director

Jessica Keenan Smith is a patient advocate and epilepsy community leader with more than 15 years of experience. As Founder and CEO of Living Well With Epilepsy and Executive Director of ASENT she bridges the gap between the scientific and patient communities, with a particular focus on the needs of the epilepsies. Jessica Keenan Smith is Founder and CEO of Living Well With Epilepsy, an award winning online resource for people affected by epilepsy to share stories and access in-depth information on the disease. Since 2009, Living Well With Epilepsy (https://livingwellwithepilepsy.com) has been featured in Forbes, Wired, NBC, NPR and the cover story of Epilepsy Advocate Magazine and has partnered with companies such as UCB, Lundbeck, Sunovion, Eisai, and more. Ms. Smith is also the Executive Director of the American Society for Experimental Neurotherapeutics (ASENT) (https://asent.org), an organization that brings together leaders from industry, academia, government and advocacy who are engaged in bringing drugs and devices to market across all neurologic disease states. In this role she is responsible for leading a successful scientific journal and annual scientific conference with speakers from all over the world.

See Full Bio